These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8855511)

  • 1. Characterization of substance P release from the intermediate area of rat thoracic spinal cord.
    Yang L; Thomas ND; Helke CJ
    Synapse; 1996 Aug; 23(4):265-73. PubMed ID: 8855511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of [3H]5-hydroxytryptamine from the intermediate area of rat thoracic spinal cord is modulated by presynaptic autoreceptors.
    Yang L; Jacocks HM; Helke CJ
    Synapse; 1994 Nov; 18(3):198-204. PubMed ID: 7855732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance P enhances the release of endogenous serotonin from rat ventral spinal cord.
    Franck J; Fried G; Brodin E
    Eur J Pharmacol; 1989 Dec; 174(1):85-90. PubMed ID: 2482192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.
    Malcangio M; Bowery NG
    Br J Pharmacol; 1994 Oct; 113(2):635-41. PubMed ID: 7530576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin-releasing hormone in spinal cord: coexistence with serotonin and with substance P in fibers and terminals apposing identified preganglionic sympathetic neurons.
    Appel NM; Wessendorf MW; Elde RP
    Brain Res; 1987 Jul; 415(1):137-43. PubMed ID: 2441808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A thyrotropin-releasing hormone-containing system in the rat dorsal horn separate from serotonin.
    Harkness DH; Brownfield MS
    Brain Res; 1986 Oct; 384(2):323-33. PubMed ID: 3096489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serotoninergic bulbospinal system and brainstem-spinal cord content of serotonin-, TRH-, and substance P-like immunoreactivity in the aged rat with special reference to the spinal cord motor nucleus.
    Johnson H; Ulfhake B; Dagerlind A; Bennett GW; Fone KC; Hökfelt T
    Synapse; 1993 Sep; 15(1):63-89. PubMed ID: 7508641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of enzymatic degradation in the inactivation of tachykinin neurotransmitters in neonatal rat spinal cord.
    Suzuki H; Yoshioka K; Yanagisawa M; Urayama O; Kurihara T; Hosoki R; Saito K; Otsuka M
    Br J Pharmacol; 1994 Sep; 113(1):310-6. PubMed ID: 7529113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tachykinin induced regulation of excitatory amino acid responses in the rat spinal cord in vitro.
    Urban L; Naeem S; Patel IA; Dray A
    Neurosci Lett; 1994 Feb; 168(1-2):185-8. PubMed ID: 7518061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin-releasing hormone-immunoreactive neurons project from the ventral medulla to the intermediolateral cell column: partial coexistence with serotonin.
    Helke CJ; Sayson SC; Keeler JR; Charlton CG
    Brain Res; 1986 Aug; 381(1):1-7. PubMed ID: 2428429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P and neurokinin A, two coexisting tachykinins stimulating the release of [3H]5-HT from rat cerebral cortical slices.
    Iverfeldt K; Solti M; Bartfai T
    Brain Res; 1990 Jan; 506(2):335-8. PubMed ID: 1689200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential contribution of substance P and neurokinin A to spinal cord neurokinin-1 receptor signaling in the rat.
    Trafton JA; Abbadie C; Basbaum AI
    J Neurosci; 2001 May; 21(10):3656-64. PubMed ID: 11331395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment.
    Iverfeldt K; Peterson LL; Brodin E; Ogren SO; Bartfai T
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):1-6. PubMed ID: 2426604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential release of endogenous 5-hydroxytryptamine, substance P, and neurokinin A from rat ventral spinal cord in response to electrical stimulation.
    Franck J; Brodin E; Fried G
    J Neurochem; 1993 Aug; 61(2):704-11. PubMed ID: 7687660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo characterization of the tachykinin receptors involved in the direct and indirect bronchoconstrictor effect of tachykinins in two inbred rat strains.
    Joos GF; Kips JC; Pauwels RA
    Am J Respir Crit Care Med; 1994 May; 149(5):1160-6. PubMed ID: 7513594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT3 receptor antagonists inhibit sensory neuropeptide release from the rat spinal cord.
    Saria A; Javorsky F; Humpel C; Gamse R
    Neuroreport; 1990 Oct; 1(2):104-6. PubMed ID: 1717037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tachykinin release from rat spinal cord in vitro and in vivo in response to various stimuli.
    Linderoth B; Brodin E
    Regul Pept; 1988 May; 21(1-2):129-40. PubMed ID: 2455922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization and release of 5-hydroxytryptamine thyrotrophin releasing hormone and substance P in rat ventral spinal cord.
    Marsden CA; Bennett GW; Irons J; Gilbert RF; Emson PC
    Comp Biochem Physiol C Comp Pharmacol; 1982; 72(2):263-70. PubMed ID: 6183051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
    Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.